Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.
3.
4.

Allograft cytotoxicity. Role of T lymphocytes bearing a receptor for complement.

Arnaiz-Villena A, Jones B, Roitt IM.

Immunology. 1975 Nov;29(5):903-8.

7.

Human lymphocyte cytotoxicity against mumps virus-infected target cells. Requirement for non-T cells.

Härfast B, Andersson T, Perlmann P.

J Immunol. 1975 Jun;114(6):1820-3.

PMID:
1168673
8.

Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: characterization of effector cells.

West WH, Cannon GB, Kay HD, Bonnard GD, Herberman RB.

J Immunol. 1977 Jan;118(1):355-61.

PMID:
299761
10.
11.
13.

Cytotoxicity responses to melanoma cells by human lymphoid cell subpopulations.

O'Neill PA, Mackler BF, Romsdahl MM.

J Natl Cancer Inst. 1976 Aug;57(2):431-4.

PMID:
1087348
14.

Cell-mediate cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (igr3).

Peter HH, Pavie-Fischer J, Fridman WH, Aubert C, Cesarini JP, Roubin R, Kourilsky FM.

J Immunol. 1975 Aug;115(2):539-48.

PMID:
1171141
15.

Induction of cytolytic T- and B-cell responses against influenza virus infections.

Armerding D, Rossiter H.

Infect Immun. 1980 Jun;28(3):799-811.

19.

Antibodies to human T lymphocytes in xenoantisera elicited with a new immature T-cell line (Peer).

Schlesinger M, Rabinowitz R, Kertes T, Ravid Z, Goldblum N.

Thymus. 1981 Feb;2(4-5):235-43.

PMID:
7015584
Items per page

Supplemental Content

Support Center